Patents by Inventor Susan Henke

Susan Henke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7445641
    Abstract: The present invention relates to biomaterials modified with non-proteinaceous catalysts for the dismutation of superoxide, and processes for making such materials. This modification may be by covalent conjugation, copolymerization, or admixture of the non-proteinaceous catalysts with the biomaterial. The resulting modified biomaterials exhibit a marked decrease in inflammatory response and subsequent degradation when placed in contact with vertebrate biological systems.
    Type: Grant
    Filed: May 26, 2000
    Date of Patent: November 4, 2008
    Assignee: Pharmacia Corporation
    Inventors: Richard Ornberg, Kishore Udipi, Denis Forster, Dennis Riley, Bruce Thurmond, Susan Henke, Kerry Brethauer
  • Publication number: 20060089710
    Abstract: This invention provides modified biopolymers comprising biopolymers attached to at least one non-proteinaceous catalyst capable of dismutating superoxide in the biological system or precursor ligand thereof. The invention further provides pharmaceutical compositions comprising the modified biopolymer and therapeutic methods comprising administering the modified biopolymer to a subject in need thereof.
    Type: Application
    Filed: September 15, 2005
    Publication date: April 27, 2006
    Inventors: Richard Ornberg, Kishore Udipi, Denis Forster, Dennis Riley, Kenneth Thurmond, Susan Henke, Kerry Brethauer, Saikat Joardar
  • Patent number: 7004976
    Abstract: This invention provides modified biopolymers comprising biopolymers attached to at least one non-proteinaceous catalyst capable of dismutating superoxide in the biological system or precursor ligand thereof. The invention further provides pharmaceutical compositions comprising the modified biopolymer and therapeutic methods comprising administering the modified biopolymer to a subject in need thereof.
    Type: Grant
    Filed: November 5, 2003
    Date of Patent: February 28, 2006
    Assignee: Pharmacia Corporation
    Inventors: Richard L. Ornberg, Kishore Udipi, Denis Forster, Dennis P. Riley, Kenneth B. Thurmond, Susan Henke, Kerry Brethaur, Saikat Joardar
  • Publication number: 20050261130
    Abstract: A herbicidal composition is provided comprising an aqueous solution of N-phosphonomethylglycine, predominantly in the form of the potassium salt thereof, at a concentration of at least 300 g a.e./l of the composition; and a surfactant component in solution or stable suspension, emulsion, or dispersion in the water, comprising one or more surfactants in a total amount of about 20 to about 300 g/l of the composition, wherein the composition has a viscosity of less than about 250 centipoise at 0° C. or a Gardner color value less than 10.
    Type: Application
    Filed: May 5, 2005
    Publication date: November 24, 2005
    Applicant: Monsanto Technology LLC
    Inventors: Patrick Lennon, Xiangyang Chen, Graciela Arhancet, Jeanette Glaenzer, Jane Gillespie, Jeffrey Graham, David Becher, Daniel Wright, Henry Agbaje, Xiaodong Xu, William Abraham, Ronald Brinker, Norman Pallas, Al Wideman, Martin Mahoney, Susan Henke
  • Publication number: 20040116332
    Abstract: This invention provides modified biopolymers comprising biopolymers attached to at least one non-proteinaceous catalyst capable of dismutating superoxide in the biological system or precursor ligand thereof. The invention further provides pharmaceutical compositions comprising the modified biopolymer and therapeutic methods comprising administering the modified biopolymer to a subject in need thereof.
    Type: Application
    Filed: November 5, 2003
    Publication date: June 17, 2004
    Inventors: Richard L. Ornberg, Kishore Udipi, Denis Forster, Dennis P. Riley, Kenneth B. Thurmond, Susan Henke, Kerry Brethauer, Saikat Joardar
  • Publication number: 20040110722
    Abstract: The present invention relates to hyaluronic acid polymers modified with non-proteinaceous catalysts for the dismutation of superoxide, and processes for making such materials. The invention further provides pharmaceutical compositions comprising the modified biopolymer and therapeutic methods comprising administering the modified biopolymer to a subject in need thereof.
    Type: Application
    Filed: November 5, 2003
    Publication date: June 10, 2004
    Inventors: Richard L. Ornberg, Kishore Udipi, Denis Forster, Dennis P. Riley, Kenneth B. Thurmond, Susan Henke, Kerry Brethauer, Saikat Joardar